share_log

Marker Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Eansor Norman David

SEC announcement ·  Jun 8, 2023 21:35
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more